BMS-986393: GPRC5D-targeted CAR for R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:10 1 year ago 259 Скачать Далее
Clinical Activity of BMS-986393, a CAR T cell therapy directed at GPRC5D, in Pts with RRMM International Myeloma Foundation 8:06 1 year ago 361 Скачать Далее
GPRC5D-Targeted CAR T-Cell Therapy for RRMM: Phase 1 Study Outcomes of BMS-986393 (CC-95266) International Myeloma Foundation 6:58 1 year ago 600 Скачать Далее
BMS-986393, a novel anti-GPRC5D CAR-T cell therapy, in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:27 11 months ago 300 Скачать Далее
BMS-986393 CAR T-cell therapy for R/R multiple myeloma: results of a Phase I trial VJHemOnc – Video Journal of Hematology & HemOnc 2:14 8 months ago 147 Скачать Далее
Promise of GPRC5D-targeted CAR-T therapies in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 0:36 1 year ago 95 Скачать Далее
A New Target for CAR-T Therapy in Myeloma - GPRC5D | Fredrik Schjesvold, MD | ASH 2021 HealthTree Foundation for Multiple Myeloma 1:47 2 years ago 363 Скачать Далее
Dr Hernandez-Ilizaliturri on the Use of CAR T-Cell Therapy in R/R Multiple Myeloma OncLive 2:17 3 weeks ago 43 Скачать Далее
Will CAR-T be best when used in early relapse in myeloma? VJHemOnc – Video Journal of Hematology & HemOnc 2:16 1 day ago 115 Скачать Далее
PHE885, a T-Charge manufactured BCMA-directed CAR-T therapy in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:53 1 year ago 213 Скачать Далее
WGS reveals sequential & persistent loss of BCMA and GPRC5D after bispecific antibodies in myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:47 9 months ago 28 Скачать Далее
Bispecific antibodies vs CAR T-cells for R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 4:35 2 years ago 294 Скачать Далее
Phase I study of CART-ddBCMA in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 0:59 2 years ago 286 Скачать Далее
The value of CAR-T cell therapy for the treatment of R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:00 1 year ago 263 Скачать Далее
Talquetamab: GPRC5D-CD3 bispecific antibody in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 4:15 3 years ago 548 Скачать Далее
Safety & efficacy of cesnicabtagene autoleucel (ARI0002H) in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 5:35 2 years ago 104 Скачать Далее
Bispecifics & CARs: BCMA, GPRC5D & FcRH5 sequencing VJHemOnc – Video Journal of Hematology & HemOnc 1:24 1 year ago 117 Скачать Далее
Using dual-targeting CAR-Ts to overcome CAF-induced CAR-T resistance in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:03 2 years ago 105 Скачать Далее
CAR T-Cell Therapy for R/R Multiple Myeloma: Sharing Expert Insights to Advance Outcomes Medscape 36:14 3 months ago 3 Скачать Далее
Dr. Shah on BCMA-Directed CAR T-Cell Therapy Research in R/R Multiple Myeloma OncLive 1:02 4 years ago 112 Скачать Далее
